Skip to main content
Erschienen in: Lung 6/2015

01.12.2015

Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes

verfasst von: Michal Shteinberg, Joseph Rivlin, Michal Gur, Muriel Konopnicki, Nili Stein, Michael M. Tunney, J. Stuart Elborn, Damian G. Downey, Elinor Johnston, Hadar Shalom, Andrew Levy

Erschienen in: Lung | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Haptoglobin (Hp), a heme-Iron chelator, has different isoforms which are associated with variable tendency toward infections: Hp 1-1, Hp 2-1, and Hp 2-2. Cystic fibrosis (CF) outcomes are variable and influenced by genetic and environmental factors. The aim of this study was to determine whether Hp phenotype influenced disease severity in CF. One hundred forty-two CF patients from two centers were analyzed for Haptoglobin phenotype using gel electrophoresis of hemoglobin enriched serum. Clinical and microbiological data including bacterial colonization status, lung function, presence of CF-related diabetes and liver disease, rate of exacerbation, and mortality were compared between Hp phenotype groups. We found a trend toward less mucoid PA among Hp 2-2 (20.4 %) compared with Hp 1-1 and Hp 2-1 individuals (33.3 %), p = 0.317. Hp 2-2 individuals also had less antibiotic courses, and lower inflammatory markers without statistical significance. Haptoglobin phenotype is unlikely to be an important modifier of CF phenotype.
Literatur
1.
Zurück zum Zitat Guillot L, Beucher J, Tabary O, Le Rouzic P, Clement A, Corvol H (2014) Lung disease modifier genes in cystic fibrosis. Int J Biochem Cell Biol 52:83–93CrossRefPubMed Guillot L, Beucher J, Tabary O, Le Rouzic P, Clement A, Corvol H (2014) Lung disease modifier genes in cystic fibrosis. Int J Biochem Cell Biol 52:83–93CrossRefPubMed
2.
Zurück zum Zitat Mogayzel PJ, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B, Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B (2013) Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 187(7):680–689CrossRefPubMed Mogayzel PJ, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B, Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B (2013) Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 187(7):680–689CrossRefPubMed
3.
Zurück zum Zitat Kim EJ, Sabra W, Zeng AP (2003) Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology 149(Pt 9):2627–2634CrossRefPubMed Kim EJ, Sabra W, Zeng AP (2003) Iron deficiency leads to inhibition of oxygen transfer and enhanced formation of virulence factors in cultures of Pseudomonas aeruginosa PAO1. Microbiology 149(Pt 9):2627–2634CrossRefPubMed
4.
Zurück zum Zitat Berlutti F, Morea C, Battistoni A, Sarli S, Cipriani P, Superti F, Ammendolia MG, Valenti P (2005) Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 18(4):661–670PubMed Berlutti F, Morea C, Battistoni A, Sarli S, Cipriani P, Superti F, Ammendolia MG, Valenti P (2005) Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 18(4):661–670PubMed
5.
Zurück zum Zitat Berlutti F, Superti F, Nicoletti M, Morea C, Frioni A, Ammendolia MG, Battistoni A, Valenti P (2008) Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 21(1):51–59PubMed Berlutti F, Superti F, Nicoletti M, Morea C, Frioni A, Ammendolia MG, Battistoni A, Valenti P (2008) Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol 21(1):51–59PubMed
6.
Zurück zum Zitat O’May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW (2009) Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 58(Pt 6):765–773CrossRefPubMed O’May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW (2009) Iron-binding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 58(Pt 6):765–773CrossRefPubMed
7.
Zurück zum Zitat Valenti P, Catizone A, Pantanella F, Frioni A, Natalizi T, Tendini M, Berlutti F (2011) Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm. Int J Immunopathol Pharmacol 24(4):1057–1068PubMed Valenti P, Catizone A, Pantanella F, Frioni A, Natalizi T, Tendini M, Berlutti F (2011) Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm. Int J Immunopathol Pharmacol 24(4):1057–1068PubMed
8.
Zurück zum Zitat Vogel AR, Szelestey BR, Raffel FK, Sharpe SW, Gearinger RL, Justice SS, Mason KM (2012) SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus. Front Cell Infect Microbiol 2:42PubMedCentralCrossRefPubMed Vogel AR, Szelestey BR, Raffel FK, Sharpe SW, Gearinger RL, Justice SS, Mason KM (2012) SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus. Front Cell Infect Microbiol 2:42PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O’Toole GA, Stanton BA (2008) The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Cell Mol Physiol 295(1):L25–L37CrossRef Moreau-Marquis S, Bomberger JM, Anderson GG, Swiatecka-Urban A, Ye S, O’Toole GA, Stanton BA (2008) The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability. Am J Physiol Cell Mol Physiol 295(1):L25–L37CrossRef
10.
Zurück zum Zitat Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R (2010) Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 12(2):293–304CrossRefPubMed Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R (2010) Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 12(2):293–304CrossRefPubMed
11.
Zurück zum Zitat Burbea Z, Nakhoul F, Zoabi R, Hochberg I, Levy NS, Benchetrit S, Weissgarten J, Tovbin D, Knecht A, Iaina A, Herman M, Kristal B, Levy AP (2004) Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients. Ann Clin Biochem 41(Pt 6):469–473CrossRefPubMed Burbea Z, Nakhoul F, Zoabi R, Hochberg I, Levy NS, Benchetrit S, Weissgarten J, Tovbin D, Knecht A, Iaina A, Herman M, Kristal B, Levy AP (2004) Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients. Ann Clin Biochem 41(Pt 6):469–473CrossRefPubMed
12.
Zurück zum Zitat Wasserzug O, Blum S, Klement E, Lejbkowicz F, Miller-Lotan R, Levy AP (2007) Haptoglobin 1-1 genotype and the risk of life-threatening streptococcus infection: evolutionary implications. J Infect 54(4):410CrossRefPubMed Wasserzug O, Blum S, Klement E, Lejbkowicz F, Miller-Lotan R, Levy AP (2007) Haptoglobin 1-1 genotype and the risk of life-threatening streptococcus infection: evolutionary implications. J Infect 54(4):410CrossRefPubMed
13.
Zurück zum Zitat Kasvosve I, Speeckaert MM, Speeckaert R, Masukume G, Delanghe JR (2010) Haptoglobin polymorphism and infection. Adv Clin Chem 50:23–46CrossRefPubMed Kasvosve I, Speeckaert MM, Speeckaert R, Masukume G, Delanghe JR (2010) Haptoglobin polymorphism and infection. Adv Clin Chem 50:23–46CrossRefPubMed
14.
Zurück zum Zitat Kerem E, Kerem B (1996) Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 22(6):387–395CrossRefPubMed Kerem E, Kerem B (1996) Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol 22(6):387–395CrossRefPubMed
15.
Zurück zum Zitat Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42(10):1589–1600PubMed Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42(10):1589–1600PubMed
16.
Zurück zum Zitat Chillappagari S, Venkatesan S, Garapati V, Mahavadi P, Munder A, Seubert A, Sarode G, Guenther A, Schmeck BT, Tummler B, Henke MO (2014) Impaired TLR4 and HIF expression in cystic fibrosis bronchial epithelial cells downregulates hemeoxygenase-1 and alters iron homeostasis in vitro. Am J Physiol Cell Mol Physiol 307(10):L791–L799CrossRef Chillappagari S, Venkatesan S, Garapati V, Mahavadi P, Munder A, Seubert A, Sarode G, Guenther A, Schmeck BT, Tummler B, Henke MO (2014) Impaired TLR4 and HIF expression in cystic fibrosis bronchial epithelial cells downregulates hemeoxygenase-1 and alters iron homeostasis in vitro. Am J Physiol Cell Mol Physiol 307(10):L791–L799CrossRef
17.
Zurück zum Zitat Delanghe J, Langlois M, Ouyang J, Claeys G, De Buyzere M, Wuyts B (1998) Effect of haptoglobin phenotypes on growth of Streptococcus pyogenes. Clin Chem Lab Med 36(9):691–696CrossRefPubMed Delanghe J, Langlois M, Ouyang J, Claeys G, De Buyzere M, Wuyts B (1998) Effect of haptoglobin phenotypes on growth of Streptococcus pyogenes. Clin Chem Lab Med 36(9):691–696CrossRefPubMed
18.
Zurück zum Zitat Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409(6817):198–201CrossRefPubMed Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409(6817):198–201CrossRefPubMed
19.
Zurück zum Zitat McKone EF, Shao J, Frangolias DD, Keener CL, Shephard CA, Farin FM, Tonelli MR, Pare PD, Sandford AJ, Aitken ML (2006) Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease. Am J Respir Crit Care Med 174(4):415–419PubMedCentralCrossRefPubMed McKone EF, Shao J, Frangolias DD, Keener CL, Shephard CA, Farin FM, Tonelli MR, Pare PD, Sandford AJ, Aitken ML (2006) Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease. Am J Respir Crit Care Med 174(4):415–419PubMedCentralCrossRefPubMed
Metadaten
Titel
Lack of Association Between Haptoglobin Phenotype and Cystic Fibrosis Outcomes
verfasst von
Michal Shteinberg
Joseph Rivlin
Michal Gur
Muriel Konopnicki
Nili Stein
Michael M. Tunney
J. Stuart Elborn
Damian G. Downey
Elinor Johnston
Hadar Shalom
Andrew Levy
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Lung / Ausgabe 6/2015
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-015-9801-z

Weitere Artikel der Ausgabe 6/2015

Lung 6/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.